Psoriasis During Pregnancy — What Changes, What Is Safe, and What to Expect

The immune shift in pregnancy: for a pregnancy to succeed, the maternal immune system must tolerate the foetus — genetically half foreign. The body achieves this through a shift away from Th1/Th17 immune activity (which drives psoriasis) toward Th2 activity. Since psoriasis is driven by Th17/Th1 cytokines (IL-17, IL-23, TNF-alpha), and pregnancy suppresses precisely this pathway — psoriasis naturally improves in many women.

Elevated progesterone and oestrogen: progesterone has immunosuppressive effects contributing to the Th2 shift. Oestrogen at high pregnancy levels has anti-inflammatory effects on psoriatic pathways.

When improvement occurs: typically apparent in the second trimester as hormone levels stabilise and rise. First trimester can be unpredictable — some women worsen initially before improving.

Why some worsen: different immune profiles, specific pregnancy-related triggers (stress, sleep disruption, nutritional changes). Pustular psoriasis of pregnancy (impetigo herpetiformis) — rare but serious, requires urgent medical management — is distinct from ordinary plaque psoriasis.

The postpartum rebound: the Th2 shift reverses after delivery — often rapidly. Many women who improved dramatically during pregnancy experience a significant postpartum rebound, sometimes worse than pre-pregnancy levels. This is biologically expected — plan for it, do not be surprised by it.

Absolutely contraindicated:

Requires careful specialist assessment:

Generally safe:

Step 1 — Non-pharmacological: emollients twice daily (especially after showering). Stress management — prenatal yoga, breathing exercises, adequate sleep. Lukewarm showers, brief. Natural midday sun exposure 15-30 minutes several times weekly — safe in pregnancy, Indian climate provides this.

Step 2 — Topical for localised flares: mild-to-moderate topical corticosteroids on limited areas, acceptable for short-term. Calcipotriol for localised patches.

Step 3 — NB-UVB for widespread flares: when topicals insufficient — NB-UVB is the safest systemic-equivalent option in pregnancy. Folate supplementation alongside. Requires dermatology referral.

Step 4 — Systemic for severe cases: cyclosporin under specialist guidance, or in very severe cases — selected biologics (TNF inhibitors first/second trimester) under joint rheumatology-obstetric care. Not primary care decisions.

Planning the postpartum rebound: discuss with treating doctor before delivery — what is the plan when psoriasis rebounds? Having topical treatment ready, NB-UVB referral arranged, or constitutional homoeopathic treatment already started = proactive management rather than reactive crisis.

Restricted during breastfeeding:

Safe during breastfeeding: emollients, topical corticosteroids (not on nipple/areola), calcipotriol (not on breast area), NB-UVB.

The postpartum reality: a new mother dealing with significant psoriasis rebound while breastfeeding has very limited pharmacological options. Exhaustion, hormonal shift, sleep deprivation — all additional triggers. The combination can be extremely distressing. This is the context in which non-pharmacological approaches (and homoeopathic treatment specifically) have their most compelling practical case.

Medication timing before conception:

Folic acid: all women planning pregnancy take folic acid (5 mg daily if previously on methotrexate; standard 400 mcg otherwise). NB-UVB also requires folate supplementation.

The genetic question: if both parents have psoriasis, child's risk approximately 50%. One parent — approximately 10-25%. Not a reason to avoid pregnancy — psoriasis is manageable — but parents should know to recognise it early in the child.

Obstetric considerations: well-controlled psoriasis does not significantly affect pregnancy outcomes. Severe, uncontrolled psoriasis (especially generalised pustular) — slightly increased complications risk. Maintaining reasonable control during pregnancy is worthwhile.

Pregnancy psoriasis presents the most compelling case for constitutional homoeopathic treatment of any psoriasis context — because the pharmacological treatment gap is widest here.

Most systemic medications are contraindicated. NB-UVB requires dermatology referral and travel multiple times weekly — not always practical during pregnancy. Topicals have safety limitations. The patient who improves needs no additional treatment. But the patient who does not improve, or who faces a significant postpartum rebound, needs options — and pharmacological options are genuinely limited.

Homoeopathic constitutional medicines are not contraindicated in pregnancy. No teratogenic risk at constitutional treatment doses. No documented drug interactions with obstetric medications (tocolytics, prenatal antihypertensives, prenatal vitamins). Safe for the foetus at all gestational stages. Same applies during breastfeeding. This is not theoretical — it is the absence of any documented pharmacological risk combined with extensive clinical use.

What constitutional treatment does: it works with the body's existing immune state. During pregnancy, the immune system has already shifted toward Th2 dominance — the body's own mechanism improving psoriasis. Constitutional treatment supports the overall constitutional picture during this period — vitality, stress response, sleep quality — without pharmacological immune manipulation.

For the postpartum rebound: starting constitutional homoeopathic treatment in the third trimester means treatment is already active when the Th2-to-Th1 rebound occurs after delivery. Proactive approach — not waiting for the rebound to become severe before starting — is the practical recommendation.

For women who worsen during first trimester: constitutional treatment is the primary option when most medications are most restricted.

Dr. Shadab Khan — Akola, Maharashtra — WhatsApp 8983458889 — pregnancy and postpartum psoriasis consultations online India-wide.